(Q37845414)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21338381%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

review article

1 reference

title

Th17 cell, the new player of neuroinflammatory process in multiple sclerosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21338381%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

0 references

Farhad Jadidi-Niaragh

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21338381%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

Abbas Mirshafiey

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21338381%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

author name string

A Mirshafiey

series ordinal

2

1 reference

24 August 2017

1 July 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21338381%20AND%20SRC:MED&resulttype=core&format=json

Scandinavian Journal of Immunology

23 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21338381%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

volume

74

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21338381%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21338381%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

page(s)

1-13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21338381%20AND%20SRC:MED&resulttype=core&format=json

Novel immunosuppressive therapy by M2000 in experimental multiple sclerosis

23 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02536.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02536.X

Current views on the roles of Th1 and Th17 cells in experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02536.X

Phenotypical and functional characterization of T helper 17 cells in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02536.X

C-C chemokine receptor 6-regulated entry of TH-17 cells into the CNS through the choroid plexus is required for the initiation of EAE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02536.X

Multiple sclerosis--the plaque and its pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02536.X

Histamine and histamine receptors in pathogenesis and treatment of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02536.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02536.X

The pathology of multiple sclerosis is the result of focal inflammatory demyelination with axonal damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02536.X

A genetic basis for familial aggregation in multiple sclerosis. Canadian Collaborative Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02536.X

Association of the APOE epsilon4 allele with disease activity in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02536.X

TCR beta polymorphisms and multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02536.X

Regulatory and pro-inflammatory phenotypes of myelin basic protein-autoreactive T cells in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02536.X

Two genes encoding immune-regulatory molecules (LAG3 and IL7R) confer susceptibility to multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02536.X

HLA-DR15 haplotype and multiple sclerosis: a HuGE review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02536.X

Redundancy in antigen-presenting function of the HLA-DR and -DQ molecules in the multiple sclerosis-associated HLA-DR2 haplotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02536.X

An extremes of outcome strategy provides evidence that multiple sclerosis severity is determined by alleles at the HLA-DRB1 locus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02536.X

Protective role of the HLA-A*02 allele in Portuguese patients with multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02536.X

Association between protective and deleterious HLA alleles with multiple sclerosis in Central East Sardinia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02536.X

Immunology of multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02536.X

Axonal loss in the pathology of MS: consequences for understanding the progressive phase of the disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02536.X

Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02536.X

Neuroprotection from complement-mediated inflammatory damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02536.X

Prostaglandins in pathogenesis and treatment of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02536.X

Chronological changes of CD4(+) and CD8(+) T cell subsets in the experimental autoimmune encephalomyelitis, a mouse model of multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02536.X

Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02536.X

Myelin basic protein-specific T helper 2 (Th2) cells cause experimental autoimmune encephalomyelitis in immunodeficient hosts rather than protect them from the disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02536.X

Decreased FOXP3 levels in multiple sclerosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02536.X

Clonal expansions of CD8(+) T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02536.X

Cytotoxic T lymphocytes in autoimmune and degenerative CNS diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02536.X

Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02536.X

Cooperation of B cells and T cells in the pathogenesis of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02536.X

Quantitative estimation of the albumin and gamma globulin in normal and pathologic cerebrospinal fluid by immunochemical methods.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02536.X

Importance of intrathecal synthesis of IgD in multiple sclerosis. A combined clinical, immunologic, and magnetic resonance imaging study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02536.X

Microbial lipopeptides induce the production of IL-17 in Th cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02536.X

Interleukin-17 family members and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02536.X

21 January 2018

IL-17 cytokine family

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02536.X

Th17: an effector CD4 T cell lineage with regulatory T cell ties

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02536.X

Development, cytokine profile and function of human interleukin 17-producing helper T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02536.X

IL-9 induces differentiation of TH17 cells and enhances function of FoxP3+ natural regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02536.X

Th17: the third member of the effector T cell trilogy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02536.X

Distinct regulation of interleukin-17 in human T helper lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02536.X

Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02536.X

Cutting edge: Human Th17 cells are identified as bearing CCR2+CCR5- phenotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02536.X

MicroRNA miR-326 regulates TH-17 differentiation and is associated with the pathogenesis of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02536.X

IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02536.X

Essential autocrine regulation by IL-21 in the generation of inflammatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02536.X

IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02536.X

Selective regulatory function of Socs3 in the formation of IL-17-secreting T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02536.X

Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02536.X

Cutting edge: TGF-beta inhibits Th type 2 development through inhibition of GATA-3 expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02536.X

Mechanism of transforming growth factor beta-induced inhibition of T helper type 1 differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02536.X

IL-21 and IL-21R are not required for development of Th17 cells and autoimmunity in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02536.X

IL-21 is produced by Th17 cells and drives IL-17 production in a STAT3-dependent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02536.X

Interleukin-21: a modulator of lymphoid proliferation, apoptosis and differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02536.X

The interleukin 23 receptor is essential for the terminal differentiation of interleukin 17-producing effector T helper cells in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02536.X

Discovery and biology of IL-23 and IL-27: related but functionally distinct regulators of inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02536.X

Development, regulation and functional capacities of Th17 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02536.X

Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02536.X

Interleukin-23 promotes Th17 differentiation by inhibiting T-bet and FoxP3 and is required for elevation of interleukin-22, but not interleukin-21, in autoimmune experimental arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02536.X

The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02536.X

RORgamma t, a novel isoform of an orphan receptor, negatively regulates Fas ligand expression and IL-2 production in T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02536.X

T helper 17 lineage differentiation is programmed by orphan nuclear receptors ROR alpha and ROR gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02536.X

STAT3 regulates cytokine-mediated generation of inflammatory helper T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02536.X

Stat3 and Stat4 direct development of IL-17-secreting Th cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02536.X

The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02536.X

Aryl hydrocarbon receptor regulates Stat1 activation and participates in the development of Th17 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02536.X

Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02536.X

T-bet is a critical determinant in the instability of the IL-17-secreting T-helper phenotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02536.X

T-bet is rapidly induced by interferon-gamma in lymphoid and myeloid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02536.X

A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02536.X

T-bet negatively regulates autoimmune myocarditis by suppressing local production of interleukin 17

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02536.X

IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02536.X

New IL-12-family members: IL-23 and IL-27, cytokines with divergent functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02536.X

Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02536.X

The type I IFN induction pathway constrains Th17-mediated autoimmune inflammation in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02536.X

The lineage decisions of helper T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02536.X

IL-25 regulates Th17 function in autoimmune inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02536.X

Enforced expression of GATA3 allows differentiation of IL-17-producing cells, but constrains Th17-mediated pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02536.X

Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02536.X

Nonredundant roles for Stat5a/b in directly regulating Foxp3

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02536.X

Cutting edge: Th17 and regulatory T cell dynamics and the regulation by IL-2 in the tumor microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02536.X

Ets-1 is a negative regulator of Th17 differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02536.X

MicroRNA--managing the TH-17 inflammatory response

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02536.X

Transcriptional repressor BCL6 controls Th17 responses by controlling gene expression in both T cells and macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02536.X

The IL-23/IL-17 axis in inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02536.X

T-helper 17 cells expand in multiple sclerosis and are inhibited by interferon-beta.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02536.X

IFN-beta inhibits human Th17 cell differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02536.X

Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02536.X

Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02536.X

T helper cell type 1 (Th1), Th2 and Th17 responses to myelin basic protein and disease activity in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02536.X

Production and functions of IL-17 in microglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02536.X

Metalloproteinases in biology and pathology of the nervous system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02536.X

IL-12- and IL-23-modulated T cells induce distinct types of EAE based on histology, CNS chemokine profile, and response to cytokine inhibition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02536.X

IL-23 drives a pathogenic T cell population that induces autoimmune inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02536.X

Commensal DNA limits regulatory T cell conversion and is a natural adjuvant of intestinal immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02536.X

Th17 cells in autoimmune demyelinating disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02536.X

IL-6-deficient mice are resistant to the induction of experimental autoimmune encephalomyelitis provoked by myelin oligodendrocyte glycoprotein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02536.X

IL-6-deficient mice resist myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02536.X

Site-specific production of IL-6 in the central nervous system retargets and enhances the inflammatory response in experimental autoimmune encephalomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02536.X

Loss of CD4+ T cell IL-6R expression during inflammation underlines a role for IL-6 trans signaling in the local maintenance of Th17 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02536.X

Interleukin-17 promotes autoimmunity by triggering a positive-feedback loop via interleukin-6 induction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02536.X

Signals mediated by transforming growth factor-beta initiate autoimmune encephalomyelitis, but chronic inflammation is needed to sustain disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02536.X

Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02536.X

The differentiation of human T(H)-17 cells requires transforming growth factor-beta and induction of the nuclear receptor RORgammat

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02536.X

IL-21 and TGF-beta are required for differentiation of human T(H)17 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02536.X

IL-21 modulates CD4+ CD25+ regulatory T-cell homeostasis in experimental autoimmune encephalomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02536.X

A crucial role for interleukin (IL)-1 in the induction of IL-17-producing T cells that mediate autoimmune encephalomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02536.X

Reversible demyelination, blood-brain barrier breakdown, and pronounced neutrophil recruitment induced by chronic IL-1 expression in the brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02536.X

Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02536.X

IL-9 as a mediator of Th17-driven inflammatory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02536.X

TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02536.X

IL-23 is increased in dendritic cells in multiple sclerosis and down-regulation of IL-23 by antisense oligos increases dendritic cell IL-10 production

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02536.X

Cutting edge: IL-23 receptor gfp reporter mice reveal distinct populations of IL-17-producing cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02536.X

Anti-IL-23 therapy inhibits multiple inflammatory pathways and ameliorates autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02536.X

Repeated subcutaneous injections of IL12/23 p40 neutralising antibody, ustekinumab, in patients with relapsing-remitting multiple sclerosis: a phase II, double-blind, placebo-controlled, randomised, dose-ranging study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02536.X

Orchestrating the orchestrators: chemokines in control of T cell traffic

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02536.X

Severe disease, unaltered leukocyte migration, and reduced IFN-gamma production in CXCR3-/- mice with experimental autoimmune encephalomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02536.X

CXCR3 Signaling Reduces the Severity of Experimental Autoimmune Encephalomyelitis by Controlling the Parenchymal Distribution of Effector and Regulatory T Cells in the Central Nervous System

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02536.X

Preferential recruitment of CCR6-expressing Th17 cells to inflamed joints via CCL20 in rheumatoid arthritis and its animal model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02536.X

A role for macrophage inflammatory protein-3 alpha/CC chemokine ligand 20 in immune priming during T cell-mediated inflammation of the central nervous system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02536.X

Inhibition of CCR6 function reduces the severity of experimental autoimmune encephalomyelitis via effects on the priming phase of the immune response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02536.X

Mice deficient for CCR6 fail to control chronic experimental autoimmune encephalomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02536.X

CCR6 regulates EAE pathogenesis by controlling regulatory CD4+ T-cell recruitment to target tissues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02536.X

CCR6 regulates the migration of inflammatory and regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02536.X

Loss of T-bet, but not STAT1, prevents the development of experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02536.X

Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02536.X

Differential regulation of central nervous system autoimmunity by T(H)1 and T(H)17 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02536.X

Encephalitogenic T cells that stably express both T-bet and ROR gamma t consistently produce IFNgamma but have a spectrum of IL-17 profiles

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02536.X

Infiltration of Th1 and Th17 cells and activation of microglia in the CNS during the course of experimental autoimmune encephalomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02536.X

In vivo imaging of partially reversible th17 cell-induced neuronal dysfunction in the course of encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02536.X

Central nervous system (CNS)-resident natural killer cells suppress Th17 responses and CNS autoimmune pathology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02536.X

Induction of experimental autoimmune encephalomyelitis in C57BL/6 mice deficient in either the chemokine macrophage inflammatory protein-1alpha or its CCR5 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02536.X

Susceptibility to multiple sclerosis and the immunoglobulin heavy chain variable region

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02536.X

Metallothionein Treatment Reduces Proinflammatory Cytokines IL-6 and TNF-α and Apoptotic Cell Death during Experimental Autoimmune Encephalomyelitis (EAE)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02536.X